The Efficacy and Safety of Pemetrexed-Based Doublet Therapy Compared to Pemetrexed Alone for the Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Updated Meta-Analysis

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s88218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

CALGB 30704 (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Oncologist
Cancer ResearchMedicineOncology
2010English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Role of Pemetrexed in Advanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Controlled Trials, With Histology Subgroup Analysis

Current Oncology
Oncology
2012English

Pemetrexed as Indispensable Drug for the Treatment of Non-Squamous Non-Small Cell Lung Cancer; The Role in Induction and Maintenance Therapy

Cancer Cell & Microenvironment
2014English

P1.15-36 a Better Real World Practice for Pemetrexed in First-Line Treatment of Advanced Mon-Squamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared With Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy